Schroders PLC
11 September 2007
Schroders plc
In compliance with Rule 3.1.2R of the Disclosure and Transparency Rules,
Schroders plc was notified on 11 Septembert 2007 that the following Directors
and PDMRs of Schroders plc acquired ordinary shares of £1 each, with voting
rights attached, in Schroders plc as a result of a monthly purchase of shares
under the Company's Share Incentive Plan on 10 September 2007. In compliance
with Rule 3.1.4R of the Disclosure and Transparency Rules, Schroders plc
notifies the market of the details of the transactions:
Directors No. ordinary shares acquired Total holding of ordinary Total interest in ordinary
shares in the Share shares following this
Incentive Plan notification
Jonathan Asquith 14 408 408
Alan Brown 14 408 408
Michael Dobson 13 373 2,373
Massimo Tosato 13 373 1,373
PDMRs
Stephen Brooks 13 252 252
Markus Ruetimann 13 373 373
Graham Staples 14 408 468
Howard Trust 14 408 408
John Troiano 14 408 408
The above shares were all purchased at £13.12 per share.
11 September 2007
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.